Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
The Journal of Urology|October 1, 1995
Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimensR J Giesen, A L Huynen, R G Aarnink, et al.
British Journal of Urology|July 17, 1998
Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinomaY Xue, J Li, M A Latijnhouwers, et al.
International Journal of Cancer|February 15, 1986
Tissue-specific markers in flow cytometry of urological cancers. II. Cytokeratin and vimentin in renal-cell tumorsW F Feitz, H F Karthaus, H L Beck, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancerG A Dijkman, P F del Moral, J W Plasman, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinomaT Shimazui, E Oosterwijk, H Akaza, et al.
In Vivo (Athens, Greece)|November 1, 1991
Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-GuerinE C De Boer, W H De Jong, P A Steerenberg, et al.
Urology|February 11, 1998
Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancerH G Van der Poel, M R Van Balken, D H Schamhart, et al.
The Journal of Pathology|July 27, 1999
Molecular analysis of multifocal prostate cancer lesionsE T Ruijter, G J Miller, C A van de Kaa, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
The Journal of Urology|October 1, 1995
Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimensR J Giesen, A L Huynen, R G Aarnink, et al.
British Journal of Urology|July 17, 1998
Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinomaY Xue, J Li, M A Latijnhouwers, et al.
International Journal of Cancer|February 15, 1986
Tissue-specific markers in flow cytometry of urological cancers. II. Cytokeratin and vimentin in renal-cell tumorsW F Feitz, H F Karthaus, H L Beck, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancerG A Dijkman, P F del Moral, J W Plasman, et al.
The Journal of Urology|October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinomaF M Debruyne, L Denis, G Lunglmayer, et al.
Urology|October 1, 1994
The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancerE D Crawford, J M Kozlowski, F M Debruyne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinomaT Shimazui, E Oosterwijk, H Akaza, et al.
In Vivo (Athens, Greece)|November 1, 1991
Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-GuerinE C De Boer, W H De Jong, P A Steerenberg, et al.
Urology|February 11, 1998
Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancerH G Van der Poel, M R Van Balken, D H Schamhart, et al.
The Journal of Pathology|July 27, 1999
Molecular analysis of multifocal prostate cancer lesionsE T Ruijter, G J Miller, C A van de Kaa, et al.
Pageof 51